Order Article Reprints

de la Torre P, Paris JL, Fernández-de la Torre M, Vallet-Regí M, Flores AI. Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy. Pharmaceutics. 2021; 13(2):244. https://doi.org/10.3390/pharmaceutics13020244

de la Torre, Paz, Juan L. Paris, Miguel Fernández-de la Torre, María Vallet-Regí, and Ana I. Flores. 2021. "Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy" Pharmaceutics 13, no. 2: 244. https://doi.org/10.3390/pharmaceutics13020244

de la Torre, P., Paris, J. L., Fernández-de la Torre, M., Vallet-Regí, M., & Flores, A. I. (2021). Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy. Pharmaceutics, 13(2), 244. https://doi.org/10.3390/pharmaceutics13020244